Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fermentas International

1975 FOUNDED
M&A STATUS
401-500 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Manufacturer of molecular biological products. The company offers restriction enzymes, DNA/RNA modifying enzymes, restriction enzymes, molecular cloning, nucleic acid purification, molecular labeling and detection, RNA and DNA electrophoresis products, nucleotides and primers, transfection reagents, and reagents.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
  • 830 Harrington Court
  • Burlington, Ontario L7N 3N4
  • Canada

+1 (905) 000-0000

Fermentas International Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Fermentas International‘s full profile, request access.

Request full access to PitchBook

Fermentas International Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Fermentas International‘s full profile, request access.

Request full access to PitchBook

Fermentas International Executive Team (2)

Name Title Board
Seat
Contact
Info
Viktoras Butkus Ph.D Chairman & Chief Executive Officer
Gerhard Gerber Ph.D President

Fermentas International Board Members (4)

Name Representing Role Since Contact
Info
00000000 000000 00.0 Fermentas International Chairman & Chief Executive Officer 000 0000

3 Former Board Members

You’re viewing 1 of 4 board members. Get the full list »